Cargando…

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Respiratory syncytial virus (RSV) remains a major human pathogen, infecting the majority of infants before age two and causing re-infection throughout life. Despite decades of RSV research, there is no licensed RSV vaccine. Most candidate vaccines studied to date have incorporated the RSV fusion (F)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousa, Jarrod J., Kose, Nurgun, Matta, Pranathi, Gilchuk, Pavlo, Crowe, James E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463187/ https://www.ncbi.nlm.nih.gov/pubmed/28134924 http://dx.doi.org/10.1038/nmicrobiol.2016.271

Ejemplares similares

A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV
por: Wen, Xiaolin, et al.
Publicado: (2016)

The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein
por: Zhang, Wei, et al.
Publicado: (2019)

Antibody Epitopes of Pneumovirus Fusion Proteins
por: Huang, Jiachen, et al.
Publicado: (2019)

A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
por: Bangaru, Sandhya, et al.
Publicado: (2018)

Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
por: Wen, Xiaolin, et al.
Publicado: (2017)

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein
por: Huang, Jiachen, et al.
Publicado: (2022)

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
por: Killikelly, April M., et al.
Publicado: (2016)

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections
por: Gilchuk, Iuliia, et al.
Publicado: (2016)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Tian, Daiyin, et al.
Publicado: (2017)

Neutralizing and Epitope-Specific Antibodies against Respiratory Syncytial Virus in Maternal and Cord Blood Paired Samples
por: Mashiyama, Fumi, et al.
Publicado: (2022)

Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein
por: Cullen, Lori McGinnes, et al.
Publicado: (2015)

1611 Antibodies to conformational epitopes interfere with T20 fusion inhibition
por: Sojar, Hakimuddin, et al.
Publicado: (2014)

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV
por: Steff, Ann-Muriel, et al.
Publicado: (2017)

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus
por: Ulbrandt, Nancy D., et al.
Publicado: (2008)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
por: Murin, Charles D., et al.
Publicado: (2022)

Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus
por: Liu, Changbao, et al.
Publicado: (2007)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
por: Stewart-Jones, Guillaume B. E., et al.
Publicado: (2015)

2593. Human Monoclonal Antibodies Potently Neutralize Enterovirus D68 in both a Clade-Specific and -Independent Manner
por: Vogt, Matthew R, et al.
Publicado: (2019)

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
por: Xie, Qingqing, et al.
Publicado: (2019)

An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Zuniga, Armando, et al.
Publicado: (2021)

Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein
por: Jaberolansar, Noushin, et al.
Publicado: (2017)

Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein
por: Tang, Wei, et al.
Publicado: (2021)

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
por: Papenburg, Jesse, et al.
Publicado: (2012)

Discovery of N-Containing (-)-Borneol Esters as Respiratory Syncytial Virus Fusion Inhibitors
por: Sokolova, Anastasiya S., et al.
Publicado: (2022)

Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F
por: Harshbarger, Wayne, et al.
Publicado: (2020)

Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Zuniga, Armando, et al.
Publicado: (2021)

Molecular Epidemiology and Phylodynamics of the Human Respiratory Syncytial Virus Fusion Protein in Northern Taiwan
por: Chi, Hsin, et al.
Publicado: (2013)

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
por: Boyington, Jeffrey C., et al.
Publicado: (2016)

Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine
por: Joyce, M. Gordon, et al.
Publicado: (2016)

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein
por: Flynn, Jessica A., et al.
Publicado: (2016)

A potently neutralizing human monoclonal antibody targeting an epitope in the West Nile virus E protein preferentially recognizes mature virions
por: Goo, Leslie, et al.
Publicado: (2018)

Antibody recognition of the Pneumovirus fusion protein trimer interface
por: Huang, Jiachen, et al.
Publicado: (2020)

Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies
por: Yuan, Meng, et al.
Publicado: (2019)

Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape
por: Suryadevara, Naveenchandra, et al.
Publicado: (2022)

The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
por: Smith, Scott A., et al.
Publicado: (2013)

Ehrlichia chaffeensis Outer Membrane Protein 1-Specific Human Antibody-Mediated Immunity Is Defined by Intracellular TRIM21-Dependent Innate Immune Activation and Extracellular Neutralization
por: Velayutham, Thangam Sudha, et al.
Publicado: (2019)

An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
por: Cherukuri, Anu, et al.
Publicado: (2012)

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
por: Sastry, Mallika, et al.
Publicado: (2017)

2712. Respiratory syncytial virus (RSV) pre-fusion F antibody titers in hematopoietic cell transplant recipients with upper versus lower respiratory tract infections
por: Kim, Sara R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_idsvtudo9sainob7tneno97skj